An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer
Clinical trial NCT05186545 · UNKNOWN
Trial details
- NCT number
- NCT05186545
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-01-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.